Skip to main content

Tenaya Therapeutics, Inc.

TNYA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001858848

In the last 90 days, Tenaya Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 101 institutions reported holding it in 13F filings for Q2 2026, worth $39.7M in total; no superinvestor holds it.

13F holders, Q2 2022

Institutional positions in Tenaya Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
50
+1 vs. Q1 2022
Shares held
37.1M
−283.8K (−0.8%) vs. Q1 2022
Total value
$208.6M
−$231.3M (−52.6%) vs. Q1 2022
New holders
6
11 more added
Sold out
5
21 more reduced

1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting TNYA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2022: 50 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 47 institutionsQ4 2021: 47 institutionsQ1 2022: 50 institutionsQ2 2022: 50 institutionsQ3 2022: 73 institutionsQ4 2022: 68 institutionsQ1 2023: 65 institutionsQ2 2023: 79 institutionsQ3 2023: 77 institutionsQ4 2023: 74 institutionsQ1 2024: 90 institutionsQ2 2024: 96 institutionsQ3 2024: 95 institutionsQ4 2024: 88 institutionsQ1 2025: 107 institutionsQ2 2025: 89 institutionsQ3 2025: 91 institutionsQ4 2025: 98 institutionsQ1 2026: 103 institutionsQ2 2026: 101 institutions
Value heldQ2 2022: $208.6M
Q1 2021: $0Q2 2021: $0Q3 2021: $693.4MQ4 2021: $667.6MQ1 2022: $439.9MQ2 2022: $208.6MQ3 2022: $102.2MQ4 2022: $94.7MQ1 2023: $128.3MQ2 2023: $279.7MQ3 2023: $126.8MQ4 2023: $151.4MQ1 2024: $292.9MQ2 2024: $177.0MQ3 2024: $111.2MQ4 2024: $62.8MQ1 2025: $27.7MQ2 2025: $19.3MQ3 2025: $55.6MQ4 2025: $48.8MQ1 2026: $37.5MQ2 2026: $39.7M
Institutions holding TNYA and their total value by quarter
QuarterHoldersValue
Q2 2026101$39.7M
Q1 2026103$37.5M
Q4 202598$48.8M
Q3 202591$55.6M
Q2 202589$19.3M
Q1 2025107$27.7M
Q4 202488$62.8M
Q3 202495$111.2M
Q2 202496$177.0M
Q1 202490$292.9M
Q4 202374$151.4M
Q3 202377$126.8M
Q2 202379$279.7M
Q1 202365$128.3M
Q4 202268$94.7M
Q3 202273$102.2M
Q2 202250$208.6M
Q1 202250$439.9M
Q4 202147$667.6M
Q3 202147$693.4M
Q2 20210$0
Q1 20210$0

Institutions, Q2 2022

Shares, value and share of portfolio for each institution holding Tenaya Therapeutics, Inc.; share changes are against Q1 2022.

Institutions holding TNYA in Q2 2022
InstitutionSharesValue% of portfolioChange in sharesAction
The Column Group LLC9,400,290$52.9M11.26%00.0%Unchanged
FMR LLC5,529,042$31.1M0.00%−662,966−10.7%Reduced
Casdin Capital, LLC3,586,818$20.2M1.71%00.0%Unchanged
Ra Capital Management, L.P.3,551,508$20.0M0.53%00.0%Unchanged
Price T Rowe Associates Inc3,366,780$19.0M0.00%+335,378+11.1%Added
BlackRock Inc.2,462,929$13.9M0.00%+34,057+1.4%Added
RTW Investments, LP2,458,750$13.8M0.36%00.0%Unchanged
Vanguard Group Inc1,063,536$5.99M0.00%−22,127−2.0%Reduced
Alphabet Inc.915,705$5.16M0.28%00.0%Unchanged
Euclidean Capital LLC915,705$5.16M4.38%00.0%Unchanged
Harvard Management Co Inc673,270$3.79M0.44%00.0%Unchanged
Deep Track Capital, LP483,836$2.72M0.19%−63,087−11.5%Reduced
StepStone Group LP462,163$2.60M0.28%00.0%Unchanged
State Street Corp390,422$2.20M0.00%+95,033+32.2%Added
Geode Capital Management, LLC380,641$2.14M0.00%+12,424+3.4%Added
Commodore Capital LP357,699$2.01M0.43%−156,231−30.4%Reduced
Northern Trust Corp222,115$1.25M0.00%−9,344−4.0%Reduced
Woodline Partners LP200,698$1.13M0.02%+163,130+434.2%Added
Nuveen Asset Management, LLC76,736$432.0K0.00%+24,997+48.3%Added
Bank of New York Mellon Corp68,399$385.0K0.00%−4,915−6.7%Reduced
Charles Schwab Investment Management Inc66,338$374.0K0.00%−2,366−3.4%Reduced
TD Asset Management Inc61,644$347.0K0.00%00.0%Unchanged
Citadel Advisors LLC48,960$276.0K0.00%+48,960New
Jasper Ridge Partners, L.P.44,395$250.0K0.02%00.0%Unchanged
Manufacturers Life Insurance Company, The47,850$246.4K0.00%−4,369−8.4%Reduced
Rhumbline Advisers40,015$225.0K0.00%+17,217+75.5%Added
D. E. Shaw & Co., Inc.25,440$143.0K0.00%−13,076−33.9%Reduced
Goldman Sachs Group Inc19,248$108.0K0.00%−7,923−29.2%Reduced
Bank of America Corp17,656$100.0K0.00%−649−3.5%Reduced
JPMorgan Chase & Co16,679$94.0K0.00%−5,197−23.8%Reduced
Deutsche Bank AG14,109$79.0K0.00%−2,772−16.4%Reduced
Morgan Stanley13,101$75.0K0.00%+1,564+13.6%Added
American International Group, Inc.13,080$74.0K0.00%−1,115−7.9%Reduced
California State Teachers Retirement System11,950$67.0K0.00%−258−2.1%Reduced
Millennium Management LLC11,627$65.0K0.00%+11,627New
Voya Investment Management LLC10,583$60.0K0.00%+10,583New
SG Americas Securities, LLC10,538$59.0K0.00%+10,538New
New York State Common Retirement Fund6,854$39.0K0.00%−15,731−69.7%Reduced
Amalgamated Bank3,551$20.0K0.00%+1,078+43.6%Added
Citigroup Inc2,719$15.0K0.00%+716+35.7%Added
Tower Research Capital LLC (TRC)2,742$15.0K0.00%+1,754+177.5%Added
Legal & General Group Plc2,310$13.0K0.00%−427−15.6%Reduced
Ameritas Investment Partners, Inc.2,217$12.0K0.00%00.0%Unchanged
Barclays PLC1,402$8.00K0.00%−3,240−69.8%Reduced
Wells Fargo & Company254$1.00K0.00%−17,427−98.6%Reduced
Royal Bank of Canada157$1.00K0.00%−1,601−91.1%Reduced
UBS Group AG261$1.00K0.00%−106−28.9%Reduced
Daiwa Securities Group Inc.120$1.00K0.00%00.0%Unchanged
Huntington National Bank200$1.00K0.00%+200New
Credit Suisse AG29$00.00%+29New
MetLife Investment Management0$00.00%−18,722−100.0%Sold out
State of Wisconsin Investment Board0$00.00%−18,600−100.0%Sold out
Allspring Global Investments Holdings, LLC0$00.00%−15,406−100.0%Sold out
STRS Ohio0$00.00%−3,200−100.0%Sold out
Metropolitan Life Insurance Co0$00.00%−2,194−100.0%Sold out
Amalgamated Financial Corp.––––Not filed